Volume 26, Number 7—July 2020
Synopsis
Transmission of Chikungunya Virus in an Urban Slum, Brazil
Table 1
Prevalence of previous chikungunya virus infection, determined by detection of IgG, by demographic and clinical characteristics, Salvador, Brazil, November 2016–February 2017
Characteristic | No. participants | No. positive (prevalence, %) | p value |
---|---|---|---|
Sociodemographic | |||
Sex | |||
M | 761 | 93 (12.2) | 0.60 |
F | 1,011 | 116 (11.5) | |
Age, y | |||
5–14 | 396 | 41 (8.1) | 0.35 |
15–39 | 921 | 104 (11.9) | |
≥40 | 455 | 63 (14.9) | |
Skin color | |||
Nonwhite | 1,662 | 199 (12.0) | 0.39 |
White | 110 | 10 (9.1) | |
Household per capita income in US$/day* | |||
≤5.50 | 1,429 | 171 (12.0) | 0.69 |
>5.50 | 340 | 37 (10.9) | |
Education | |||
Illiterate | 76 | 14 (18.4) | 0.06 |
Literate | 1,696 | 195 (11.5) | |
Occupation/work | |||
Yes | 604 | 60 (9.9) | 0.08 |
No | 1,164 | 148 (12.7) | |
Residence located in an unpaved street | |||
Yes | 1,003 | 139 (13.9) | 0.02 |
No | 767 | 70 (9.1) | |
Type of residence construction | |||
Plastered wall | 1,447 | 154 (10.6) | 0.04 |
Unplastered wall | 211 | 33 (15.6) | |
Wood or other material | 106 | 21 (19.8) | |
Residents per household | |||
1 | 145 | 13 (9.0) | 0.31 |
2–3 | 676 | 89 (13.2) | |
4–5 | 608 | 60 (9.0) | |
≥6 |
340 |
5 (13.5) |
|
Clinical: reported symptoms† | |||
Fever and arthralgia | |||
None | 1,212 | 111 (9.2) | <0.01 |
Only fever | 322 | 38 (11.8) | |
Only arthralgia | 89 | 20 (22.5) | |
Both, not simultaneous | 40 | 7 (17.5) | |
Both, simultaneous | 96 | 32 (33.3) | |
Myalgia | |||
Yes | 222 | 42 (18.9) | <0.01 |
No | 1,548 | 167 (10.8) | |
Rash | |||
Yes | 216 | 50 (23.2) | <0.01 |
No | 1,554 | 158 (10.2) | |
Pruritus | |||
Yes | 206 | 46 (22.3) | <0.01 |
No |
1,563 |
163 (10.4) |
|
Presumptive clinical diagnosis | |||
Chikungunya | |||
Yes | 48 | 24 (50.0) | <0.01 |
No | 1,724 | 185 (10.7) | |
Dengue | |||
Yes | 111 | 21 (18.9) | 0.02 |
No | 1,661 | 188 (11.3) | |
Zika | |||
Yes | 147 | 38 (25.9) | <0.01 |
No | 1,625 | 171 (10.5) |
*Data not shown for 3 participants.
†Reported symptoms with onset after January 2015.
Page created: April 08, 2020
Page updated: June 18, 2020
Page reviewed: June 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.